Blood-Based Neuroendocrine Tumor mRNA Signature Identifies Residual Disease and at Day 30 after Operation Predicts Tumor Recurrence with 98% Specificity

Published on Oct 1, 2020in Journal of The American College of Surgeons4.59
· DOI :10.1016/J.JAMCOLLSURG.2020.08.129
Irvin M. Modlin81
Estimated H-index: 81
,
Mark Kidd66
Estimated H-index: 66
+ 4 AuthorsAlexandra Kitz2
Estimated H-index: 2
Source
Abstract
References0
Newest
Cited By0
Newest